Detalles de la búsqueda
1.
Cause of death and excess mortality in patients with lower-risk myelodysplastic syndromes (MDS): A report from the European MDS registry.
Br J Haematol
; 200(4): 451-461, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335984
2.
Development of a core outcome set for myelodysplastic syndromes - a Delphi study from the EUMDS Registry Group.
Br J Haematol
; 191(3): 405-417, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32410281
3.
Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry.
Haematologica
; 105(3): 640-651, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31278207
4.
Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes.
Haematologica
; 105(3): 632-639, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31171638
5.
Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes.
Haematologica
; 103(1): 69-79, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29122992
6.
Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
Gastroenterology
; 149(4): 907-17.e7, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26072396
7.
Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective.
Haematologica
; 105(11): 2516-2523, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33054132
8.
Raising the standards of patient-centered outcomes research in myelodysplastic syndromes: Clinical utility and validation of the subscales of the QUALMS from the MDS-RIGHT project.
Cancer Med
; 12(6): 7529-7539, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36533415
9.
Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study.
Blood Adv
; 7(12): 2772-2783, 2023 06 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36607832
10.
Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologists.
Blood Adv
; 6(1): 1-12, 2022 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34492684
11.
Serotonin receptor 3A polymorphism c.-42C > T is associated with severe dyspepsia.
BMC Med Genet
; 12: 140, 2011 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-22014438
12.
A predictive algorithm using clinical and laboratory parameters may assist in ruling out and in diagnosing MDS.
Blood Adv
; 5(16): 3066-3075, 2021 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34387647
13.
Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial.
Lancet
; 373(9659): 215-25, 2009 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-19150702
14.
CT colonography with limited bowel preparation for the detection of colorectal neoplasia in an FOBT positive screening population.
Abdom Imaging
; 35(6): 661-8, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19888629
15.
Genotype-Guided Thiopurine Dosing Does not Lead to Additional Costs in Patients With Inflammatory Bowel Disease.
J Crohns Colitis
; 13(7): 838-845, 2019 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-30698675
16.
Patients' beliefs about medicine are associated with early thiopurine discontinuation in patients with inflammatory bowel diseases.
Eur J Gastroenterol Hepatol
; 30(2): 167-173, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29120908
17.
Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes.
Blood Adv
; 2(16): 2079-2089, 2018 08 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30126931
18.
Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study.
Leukemia
; 32(6): 1380-1392, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29572506
19.
Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS.
Leuk Res
; 67: 21-26, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29407183
20.
Pragmatic trials in primary care. Methodological challenges and solutions demonstrated by the DIAMOND-study.
BMC Med Res Methodol
; 7: 16, 2007 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-17451599